ExploreWatchlistsPricing
  1. JP-listed companies
  2. OLYMPUS CORPORATION
  3. Financials
  4. Gross profit

OLYMPUS CORPORATION (7733)

Market cap
¥1.8T
P/E ratio
18.7x
Olympus manufactures medical endoscopes and therapeutic devices for hospitals and healthcare providers worldwide, specializing in gastrointestinal, surgical, and diagnostic equipment.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndGross profit (Million JPY)YoY (%)
Mar 31, 2025683,697+9.37%
Mar 31, 2024625,123+4.74%
Mar 31, 2023596,849+4.40%
Mar 31, 2022571,695+24.41%
Mar 31, 2021459,530-8.01%
Mar 31, 2020499,567-1.96%
Mar 31, 2019509,565+175.53%
Mar 31, 2018184,937-62.36%
Mar 31, 2017491,342-8.20%
Mar 31, 2016535,237+9.27%
Mar 31, 2015489,851

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat